26 June 2026

India has enroled its first newborn in a landmark global clinical trial that could reshape how doctors treat one of the biggest killers of infants, neonatal sepsis, at a time when the antibiotics used for decades are rapidly losing their power.

Sepsis in newborns, or neonatal sepsis, is a serious medical condition that occurs when a baby younger than 28 days old has a life-threatening response to an infection.